The offering has been priced and upsized

Hyster-Yale announced pricing for US$135 million in aggregate principal amount of 7.50% convertible senior notes due in 2031. That increases the previously announced US$125 million offering size.

The release was published at 23:08 ET on November 18, or 04:08 UTC on November 19. Issuance and sale are scheduled to close on November 23, 2026, subject to customary closing conditions. Pricing does not establish that settlement has already occurred.

Coupon and maturity terms

The notes will be general senior unsecured obligations. Their annual coupon is 7.50%, payable semi-annually on May 15 and November 15, with the first payment on May 15, 2027.

Maturity is November 15, 2031, unless the notes are earlier repurchased, redeemed or converted under their terms. The release describes conditions governing conversion and redemption; the coupon alone does not describe every term of the securities.

An additional purchase option is separate

Initial purchasers have an option to buy up to US$20 million more in principal amount, for settlement within a 13-day period starting with the first issuance date. That is an option, not a confirmed addition to the US$135 million base offering.

The company estimates net proceeds of approximately US$129.7 million after purchaser discounts, commissions and estimated expenses, or US$149.1 million if the additional-note option is fully exercised. These are estimated net amounts, separate from gross principal.

Planned uses include loan repayment

Hyster-Yale intends to combine offering proceeds with cash on hand to repay US$110 million of term-loan principal, pay approximately US$13.5 million for capped-call transactions, repurchase approximately US$15 million of Class A shares and fund general corporate purposes. The existing cash contribution matters when reading these intended uses alongside the estimated net proceeds.

The notes are offered privately to persons reasonably believed to be qualified institutional buyers under Rule 144A of the US Securities Act. This is an institutional financing announcement. The stated closing, repurchases and use of proceeds remain subject to the conditions described in the issuer's release.